BCN HEALTH publishes a study evaluating the costs due to productivity losses associated to leukaemia in Spain

BCN HEALTH has published the study ‘Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain’, in the journal ‘The Euorpean Journal of Health Economics’, an international multidisciplinary peer-reviewed journal interested in publishing health economics studies that could lead to important advances for society.

BCN HEALTH conducted an analysis of the productivity losses associated to premature mortality from leukaemia in Spain between 2012 and 2021. This analysis was based in the human capital approach, which estimates the indirect costs that the disease represents for the individual, family, society or employer via the calculation of the income and productivity of an individual that are prevented when premature death occurs. To this end, statistics on mortality and salaries were extracted from the Spanish National Statistics Institute (INE). The costs of premature mortality were estimated using age- and sex-specific annual wages from death age to age of retirement.

Between 2012 and 2021, 33,751 persons died per year from leukaemis, representing a 40% of all hematological cancer deaths. Annually, 8,562 years of potential productive life were estimated to be lost on average. Productivity losses summed €1.4 billion over the 10 year period. 

More information can be found at: https://link.springer.com/article/10.1007/s10198-024-01727-6